nifedipine has been researched along with Cardiovascular Pregnancy Complications in 95 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the maternal and fetal outcome in women with mild to moderate chronic hypertension on antihypertensive drug (methyldopa or nifedipine) therapy compared to no medication." | 9.30 | Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: A multicenter randomized clinical trial. ( Abdallah, S; Gaber, W; Gamal, A; Hamza, H; Marawan, H; Rezk, M; Salama, M, 2019) |
| " Methyldopa, labetalol, and nifedipine have been perceived safe to use during pregnancy and are therefore recommended in international guidelines for treatment of hypertension." | 9.22 | Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review. ( Allegaert, K; Flint, RB; Mian, P; Schoenmakers, S; van de Vusse, D; Versmissen, J; Visser, W, 2022) |
| "Sixty-four women in the second half of pregnancy who were not in labor randomly received 10 mg nifedipine tablets (n = 55 studies) or 10 mg nifedipine capsules (n = 74 studies) if blood pressure was > or =170/110 mm Hg." | 9.10 | Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy. ( Brown, MA; Buddle, ML; Davis, GK; Farrell, T, 2002) |
| "To determine the efficacy of Nifedipine on postpartum blood Loss in patients with Pregnancy Induced Hypertension (PIH)." | 9.09 | [The effect of Nifedipine on postpartum blood loss in patients with pregnancy induced hypertension]. ( Liu, Y; Yang, X, 2000) |
| "We sought to compare the efficacies of oral nifedipine and intravenous labetalol in the acute management of hypertensive emergencies of pregnancy." | 9.09 | A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. ( Chauhan, SP; Newman, RB; Scardo, JA; Vermillion, ST, 1999) |
| "The safety of use of the calcium channel blocker nifedipine in pregnancy as it affects child development has not been well evaluated." | 9.09 | Nifedipine administered in pregnancy: effect on the development of children at 18 months. ( Bortolus, R; Chatenoud, L; Parazzini, F; Ricci, E, 2000) |
| "To determine whether nifedipine or prazosin is the more appropriate second-line antihypertensive agent in pregnancy." | 9.09 | Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial. ( Hall, DR; Odendaal, HJ; Smith, M; Steyn, DW, 2000) |
| "To compare the effect of routine treatment with the calcium channel blocker nifedipine in mild to moderate hypertension in pregnancy." | 9.08 | Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Gruppo di Studio Ipertensione in Gravidanza. ( , 1998) |
| "Sublingual nifedipine was comparable to IV hydrallazine in the treatment of acute hypertension of pregnancy." | 9.08 | Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice. ( Jegasothy, R; Paranthaman, S, 1996) |
| "Thirty women with pregnancy-induced hypertension (PIH) scheduled for Caesarean section under general anaesthesia were studied to evaluate the efficacy of sublingual nifedipine in attenuating the pressor response to laryngoscopy and tracheal intubation." | 9.07 | Nifedipine attenuates the hypertensive response to tracheal intubation in pregnancy-induced hypertension. ( Bala, I; Batra, YK; Gopalan, S; Kumar, N, 1993) |
| "To compare nifedipine (group 1) with methyldopa (group 2) in the management of pregnancy induced hypertension (PIH)." | 9.07 | A comparison of nifedipine with methyldopa in pregnancy induced hypertension. ( Jayawardana, J; Lekamge, N, 1994) |
| "The effect of nifedipine on uteroplacental blood flow was investigated in nine hypertensive women in the trimester of pregnancy and compared with the effects of a placebo in nine similar hypertensive women." | 9.06 | The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy. ( Davey, DA; Davies, N; Lindow, SW; Smith, JA, 1988) |
| "The effect of nifedipine (Adalat; Bayer-Miles)--a calcium channel blocker, which has a well-established place in nonobstetric hypertension--was compared with dihydralazine in 33 primigravidas with severe hypertension of pregnancy." | 9.06 | Nifedipine in acute hypertensive emergencies in pregnancy. ( Becker, P; Moodley, J; Seabe, SJ, 1989) |
| "Oral nifedipine is recommended along with labetalol and hydralazine for treatment of severe hypertension during pregnancy by most authorities." | 8.93 | Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis. ( Gupta, N; Kirubakaran, R; Pareek, P; Shekhar, S, 2016) |
| "The primary outcome indicators included the safety and antihypertensive efficacy of nifedipine in pregnancy; the effects of nifedipine on maternal/fetal hemodynamics; and the effect, if any, of nifedipine on perinatal outcome." | 8.79 | Use of nifedipine in the hypertensive diseases of pregnancy. ( Doering, PL; Hatton, RC; Levin, AC, 1994) |
| "Alpha-methyldopa is a regularly used antihypertensive drug during pregnancy." | 7.76 | [Methyldopa-induced acute reactive hepatitis in pregnancy, drug-metabolizing capacity of the liver]. ( Monostory, K; Ozsvár, Z; Solymossi, Z, 2010) |
| "Study aim was assessment of clinical efficacy of mono therapy with nifedipine SR/GITS and combination of nifedipine SR/GITS and bisoprolol as well as investigation of functional state of sympathoadrenal system (SAS) in pregnant women with arterial hypertension." | 7.74 | [Clinical efficacy of antihypertensive therapy of pregnant women with arterial hypertension with long acting nifedipine and bisoprolol]. ( Brytkova, IaV; Bukhonkina, IuM; Pavlova, LN; Striuk, RI, 2008) |
| "To investigate the effect of 7 to 14 days of therapy with nifedipine (sustained-release preparation) on the 24-hour blood pressure patterns of pregnant women with pre-eclampsia or chronic hypertension, and to test the utility of blood pressure monitoring in modulating the timing and dosage of the drug." | 7.69 | 24-hour blood pressure monitoring to evaluate the effects of nifedipine in pre-eclampsia and in chronic hypertension in pregnancy. ( Benedetto, C; Carandente, F; Chiarolini, L; Giarola, M; Maulà, V; Zonca, M, 1997) |
| " Description of their management, usage of nifedipine, and pregnancy outcome." | 7.69 | Sublingual nifedipine in human pregnancy. ( Gallery, ED; Györy, AZ, 1997) |
| "Nifedipine was administered to 49 pregnant women with gestational hypertension as first-line therapy, and were longitudinally studied as paired observations for 3 or 10 day intervals of treatment with nifedipine until delivery." | 7.69 | The use of nifedipine as first-line hypotensive therapy in gestational hypertension. ( Caruso, A; De Carolis, MP; De Carolis, S; Ferrazzani, S; Mancinelli, S; Romano, D, 1994) |
| "The effect of lowering the maternal blood pressure with sublingual nifedipine on the fetal heart rate was studied in 51 patients with severe pregnancy-induced hypertension." | 7.68 | Effect of nifedipine on fetal heart rate in the treatment of severe pregnancy-induced hypertension. ( Fenakel, K; Friedman, A; Lurie, S, 1990) |
| "The short-term effect of 20 mg of oral nifedipine on maternal and fetal hemodynamics was investigated in 12 women with pregnancy-induced hypertension." | 7.68 | Uterine and fetal flow velocity waveforms in hypertensive pregnancy: the effect of a single dose of nifedipine. ( Ekblad, UU; Erkkola, RU; Pirhonen, JP, 1990) |
| "The pharmacokinetics of oral nifedipine were studied in 15 women with pregnancy-induced hypertension in the third trimester of pregnancy to determine if the drug's disposition was different from that in nonpregnant patients." | 7.68 | Oral nifedipine pharmacokinetics in pregnancy-induced hypertension. ( Akl, SA; Prevost, RR; Sibai, BM; Whybrew, WD, 1992) |
| "Slow-release nifedipine has been used in the treatment of severe hypertension in 23 pregnant women." | 7.67 | Nifedipine as a second line antihypertensive drug in pregnancy. ( Beevers, DG; Constantine, G; Luesley, DM; Reynolds, AL, 1987) |
| "The calcium antagonist, nifedipine, was given orally to 21 women with acute episodes of severe hypertension during pregnancy or in the puerperium." | 7.67 | Treatment of severe pregnancy-associated hypertension with the calcium antagonist nifedipine. ( Redman, CW; Walters, BN, 1984) |
| "Nifedipine was found to be more effective than other antihypertensive medications to reduce blood pressure, particularly in patients with severe hypertension." | 6.82 | Comparative efficacy and safety of oral nifedipine with other antihypertensive medications in the management of hypertensive disorders of pregnancy: a systematic review and meta-analysis of randomized controlled trials. ( Adela, R; George, R; Joy, CA; Thomas, C; Undela, K; Varghese, B, 2022) |
| "In nifedipine-treated non-pregnant controls, only EC80 for adrenaline-induced aggregation decreased." | 6.68 | Nifedipine reduces thromboxane A2 production by platelets without changing aggregation in hypertensive pregnancy. ( Manninen, A, 1996) |
| "This was a nested cohort study of women with chronic hypertension and a singleton pregnancy recruited to the PANDA (Pregnancy And chronic hypertension: NifeDipine vs lAbetalol as antihypertensive treatment) study at one of three UK maternity units." | 5.30 | Longitudinal changes in vascular function parameters in pregnant women with chronic hypertension and association with adverse outcome: a cohort study. ( Chappell, LC; Cruickshank, JK; Khalil, A; Mills, C; Myers, JE; Nelson-Piercy, C; Seed, PT; Watt-Coote, I; Webster, LM, 2019) |
| "To assess the maternal and fetal outcome in women with mild to moderate chronic hypertension on antihypertensive drug (methyldopa or nifedipine) therapy compared to no medication." | 5.30 | Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: A multicenter randomized clinical trial. ( Abdallah, S; Gaber, W; Gamal, A; Hamza, H; Marawan, H; Rezk, M; Salama, M, 2019) |
| " Methyldopa, labetalol, and nifedipine have been perceived safe to use during pregnancy and are therefore recommended in international guidelines for treatment of hypertension." | 5.22 | Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review. ( Allegaert, K; Flint, RB; Mian, P; Schoenmakers, S; van de Vusse, D; Versmissen, J; Visser, W, 2022) |
| "Sixty-four women in the second half of pregnancy who were not in labor randomly received 10 mg nifedipine tablets (n = 55 studies) or 10 mg nifedipine capsules (n = 74 studies) if blood pressure was > or =170/110 mm Hg." | 5.10 | Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy. ( Brown, MA; Buddle, ML; Davis, GK; Farrell, T, 2002) |
| "To determine the efficacy of Nifedipine on postpartum blood Loss in patients with Pregnancy Induced Hypertension (PIH)." | 5.09 | [The effect of Nifedipine on postpartum blood loss in patients with pregnancy induced hypertension]. ( Liu, Y; Yang, X, 2000) |
| "The objective of the present study is to compare the effectiveness of transdermal glyceryl-trinitrate versus oral nifedipine in lowering blood pressure in patients affected by pregnancy-induced hypertension (PIH)." | 5.09 | 24-hour ambulatory blood pressure monitoring: a comparison between transdermal glyceryl-trinitrate and oral nifedipine. ( Facchinetti, F; Menghini, S; Neri, I; Romanini, C; Valensise, H; Volpe, A, 1999) |
| "The safety of use of the calcium channel blocker nifedipine in pregnancy as it affects child development has not been well evaluated." | 5.09 | Nifedipine administered in pregnancy: effect on the development of children at 18 months. ( Bortolus, R; Chatenoud, L; Parazzini, F; Ricci, E, 2000) |
| "To determine whether nifedipine or prazosin is the more appropriate second-line antihypertensive agent in pregnancy." | 5.09 | Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial. ( Hall, DR; Odendaal, HJ; Smith, M; Steyn, DW, 2000) |
| "We sought to compare the efficacies of oral nifedipine and intravenous labetalol in the acute management of hypertensive emergencies of pregnancy." | 5.09 | A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. ( Chauhan, SP; Newman, RB; Scardo, JA; Vermillion, ST, 1999) |
| "To compare the effect of routine treatment with the calcium channel blocker nifedipine in mild to moderate hypertension in pregnancy." | 5.08 | Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Gruppo di Studio Ipertensione in Gravidanza. ( , 1998) |
| "Sublingual nifedipine was comparable to IV hydrallazine in the treatment of acute hypertension of pregnancy." | 5.08 | Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice. ( Jegasothy, R; Paranthaman, S, 1996) |
| "Thirty women with pregnancy-induced hypertension (PIH) scheduled for Caesarean section under general anaesthesia were studied to evaluate the efficacy of sublingual nifedipine in attenuating the pressor response to laryngoscopy and tracheal intubation." | 5.07 | Nifedipine attenuates the hypertensive response to tracheal intubation in pregnancy-induced hypertension. ( Bala, I; Batra, YK; Gopalan, S; Kumar, N, 1993) |
| "To compare nifedipine (group 1) with methyldopa (group 2) in the management of pregnancy induced hypertension (PIH)." | 5.07 | A comparison of nifedipine with methyldopa in pregnancy induced hypertension. ( Jayawardana, J; Lekamge, N, 1994) |
| "The effect of nifedipine on uteroplacental blood flow was investigated in nine hypertensive women in the trimester of pregnancy and compared with the effects of a placebo in nine similar hypertensive women." | 5.06 | The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy. ( Davey, DA; Davies, N; Lindow, SW; Smith, JA, 1988) |
| "The effect of nifedipine (Adalat; Bayer-Miles)--a calcium channel blocker, which has a well-established place in nonobstetric hypertension--was compared with dihydralazine in 33 primigravidas with severe hypertension of pregnancy." | 5.06 | Nifedipine in acute hypertensive emergencies in pregnancy. ( Becker, P; Moodley, J; Seabe, SJ, 1989) |
| " The incidence of severe hypertension was significantly lower when nifedipine (odds ratio, 0." | 5.05 | Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis. ( Bellos, I; Daskalakis, G; Loutradis, D; Papapanagiotou, A; Pergialiotis, V, 2020) |
| " Glyceryl trinitrate and labetalol were associated with fewer incidences of tachycardia and palpitation respectively than hydralazine." | 4.98 | Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials. ( Sequeira, RP; Sridharan, K, 2018) |
| "Oral nifedipine is recommended along with labetalol and hydralazine for treatment of severe hypertension during pregnancy by most authorities." | 4.93 | Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis. ( Gupta, N; Kirubakaran, R; Pareek, P; Shekhar, S, 2016) |
| "Oral nifedipine, and possibly labetalol and methyldopa, are suitable options for treatment of severe hypertension in pregnancy/postpartum." | 4.90 | Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. ( Firoz, T; Gordon, R; MacDonell, K; Magee, LA; Payne, BA; Vidler, M; von Dadelszen, P, 2014) |
| "The primary outcome indicators included the safety and antihypertensive efficacy of nifedipine in pregnancy; the effects of nifedipine on maternal/fetal hemodynamics; and the effect, if any, of nifedipine on perinatal outcome." | 4.79 | Use of nifedipine in the hypertensive diseases of pregnancy. ( Doering, PL; Hatton, RC; Levin, AC, 1994) |
| "The dihydropyridine group of calcium channel blockers (type II calcium blockers) and, specifically, nifedipine are safe for use in pregnancy." | 4.79 | Nifedipine and its indications in obstetrics and gynecology. ( Childress, CH; Katz, VL, 1994) |
| " The American College of Obstetricians and Gynecologists recommends that acute-onset, severe hypertension be treated with first line-therapy (intravenous labetalol, intravenous hydralazine or oral nifedipine) within 60 minutes to reduce risk of maternal morbidity and death." | 3.96 | Identification of factors associated with delayed treatment of obstetric hypertensive emergencies. ( Akerman, MB; Elsayad, A; Halpern, TA; Heiselman, CJ; Heo, HJ; Kantorowska, A; Muscat, JC; Sicuranza, GB; Vintzileos, AM, 2020) |
| "Doppler ultrasound and myography were utilised to assess uterine artery functional and structural changes pre-pregnancy and at gestational day 18 in SHRSP (untreated and nifedipine treated) and in the normotensive Wistar-Kyoto (WKY) rat." | 3.83 | Abnormal uterine artery remodelling in the stroke prone spontaneously hypertensive rat. ( Beattie, E; Delles, C; Graham, D; Griffin, S; Indahl, M; Morgan, H; Small, HY, 2016) |
| "Alpha-methyldopa is a regularly used antihypertensive drug during pregnancy." | 3.76 | [Methyldopa-induced acute reactive hepatitis in pregnancy, drug-metabolizing capacity of the liver]. ( Monostory, K; Ozsvár, Z; Solymossi, Z, 2010) |
| " She would like to know whether she can continue using metformin during the pregnancy and also is concerned about the effect of the gastric bypass surgery." | 3.74 | A 40-year-old woman with diabetes contemplating pregnancy after gastric bypass surgery. ( Coustan, DR, 2008) |
| "Study aim was assessment of clinical efficacy of mono therapy with nifedipine SR/GITS and combination of nifedipine SR/GITS and bisoprolol as well as investigation of functional state of sympathoadrenal system (SAS) in pregnant women with arterial hypertension." | 3.74 | [Clinical efficacy of antihypertensive therapy of pregnant women with arterial hypertension with long acting nifedipine and bisoprolol]. ( Brytkova, IaV; Bukhonkina, IuM; Pavlova, LN; Striuk, RI, 2008) |
| "To assess the variation of body composition at term in patients with normal pregnancy and patients with gestational hypertension (GH) treated with nifedipine." | 3.72 | Nifedipine-induced changes in body composition in hypertensive patients at term. ( Altomare, F; Andreoli, A; Arduini, D; De Lorenzo, A; Larciprete, G; Novelli, G; Valensise, H; Vasapollo, B, 2003) |
| "In 21 pregnancies complicated by pregnancy-induced hypertension (PIH) which was treated by antihypertensive drugs (labetalol, nifedipine), fetal behavioural recordings (quiet state, C1F; active state, C2F; no coincidence, NOC) and Doppler measurements of blood flow velocity in the umbilical artery (UA) (resistance index, RI) were made on two occasions (27-32 and 33-36 weeks of gestation)." | 3.70 | Pregnancy-induced hypertension, antihypertensive drugs and the development of fetal behavioural states. ( Bruschettini, PL; Gazzolo, D; Russo, A; Santi, F; Scopesi, F; Visser, GH, 1998) |
| "To describe the clinical course of pregnancies complicated by pulmonary hypertension and treated with the pulmonary vasodilators nifedipine and prostacyclin." | 3.70 | Pulmonary hypertension in pregnancy: treatment with pulmonary vasodilators. ( Easterling, TR; Ralph, DD; Schmucker, BC, 1999) |
| "To investigate the effect of 7 to 14 days of therapy with nifedipine (sustained-release preparation) on the 24-hour blood pressure patterns of pregnant women with pre-eclampsia or chronic hypertension, and to test the utility of blood pressure monitoring in modulating the timing and dosage of the drug." | 3.69 | 24-hour blood pressure monitoring to evaluate the effects of nifedipine in pre-eclampsia and in chronic hypertension in pregnancy. ( Benedetto, C; Carandente, F; Chiarolini, L; Giarola, M; Maulà, V; Zonca, M, 1997) |
| " Description of their management, usage of nifedipine, and pregnancy outcome." | 3.69 | Sublingual nifedipine in human pregnancy. ( Gallery, ED; Györy, AZ, 1997) |
| "The efficacy of nifedipine in reducing the pressor response to AII suggests the involvement of intracellular free calcium in the vascular response to pressor agents in pregnancy, and supports the use of this drug in the treatment of pregnancy-induced hypertension." | 3.69 | Nifedipine reduces pressor responsiveness to angiotensin II in pregnant women. ( Conti, C; Garzetti, GG; Rezai, B; Romanini, C; Tranquilli, AL, 1994) |
| "Nifedipine was administered to 49 pregnant women with gestational hypertension as first-line therapy, and were longitudinally studied as paired observations for 3 or 10 day intervals of treatment with nifedipine until delivery." | 3.69 | The use of nifedipine as first-line hypotensive therapy in gestational hypertension. ( Caruso, A; De Carolis, MP; De Carolis, S; Ferrazzani, S; Mancinelli, S; Romano, D, 1994) |
| "The pharmacokinetics of oral nifedipine were studied in 15 women with pregnancy-induced hypertension in the third trimester of pregnancy to determine if the drug's disposition was different from that in nonpregnant patients." | 3.68 | Oral nifedipine pharmacokinetics in pregnancy-induced hypertension. ( Akl, SA; Prevost, RR; Sibai, BM; Whybrew, WD, 1992) |
| "The effect of lowering the maternal blood pressure with sublingual nifedipine on the fetal heart rate was studied in 51 patients with severe pregnancy-induced hypertension." | 3.68 | Effect of nifedipine on fetal heart rate in the treatment of severe pregnancy-induced hypertension. ( Fenakel, K; Friedman, A; Lurie, S, 1990) |
| "The short-term effect of 20 mg of oral nifedipine on maternal and fetal hemodynamics was investigated in 12 women with pregnancy-induced hypertension." | 3.68 | Uterine and fetal flow velocity waveforms in hypertensive pregnancy: the effect of a single dose of nifedipine. ( Ekblad, UU; Erkkola, RU; Pirhonen, JP, 1990) |
| "The calcium antagonist, nifedipine, was given orally to 21 women with acute episodes of severe hypertension during pregnancy or in the puerperium." | 3.67 | Treatment of severe pregnancy-associated hypertension with the calcium antagonist nifedipine. ( Redman, CW; Walters, BN, 1984) |
| "Slow-release nifedipine has been used in the treatment of severe hypertension in 23 pregnant women." | 3.67 | Nifedipine as a second line antihypertensive drug in pregnancy. ( Beevers, DG; Constantine, G; Luesley, DM; Reynolds, AL, 1987) |
| "Nifedipine was found to be more effective than other antihypertensive medications to reduce blood pressure, particularly in patients with severe hypertension." | 2.82 | Comparative efficacy and safety of oral nifedipine with other antihypertensive medications in the management of hypertensive disorders of pregnancy: a systematic review and meta-analysis of randomized controlled trials. ( Adela, R; George, R; Joy, CA; Thomas, C; Undela, K; Varghese, B, 2022) |
| "In nifedipine-treated non-pregnant controls, only EC80 for adrenaline-induced aggregation decreased." | 2.68 | Nifedipine reduces thromboxane A2 production by platelets without changing aggregation in hypertensive pregnancy. ( Manninen, A, 1996) |
| "Normal pregnancy is a complex and dynamic process that requires significant adaptation from the maternal system." | 2.66 | Hemodynamic Complications in Pregnancy: Preeclampsia and Beyond. ( Doherty, A; Kingdom, JC; McLaughlin, K, 2020) |
| "Pregnancy-induced hypertension is a major cause of maternal and fetal morbidity and mortality." | 2.61 | Hypertension and Pregnancy: Management and Future Risks. ( Jim, B; Reddy, S, 2019) |
| "Nifedipine is an effective and safe drug to use when tocolytic therapy is indicated for preterm labor." | 2.41 | Calcium channel blockers in the management of preterm labor and hypertension in pregnancy. ( Bos, JM; Dekker, GA; Geijn, HP; Lok, CA; Papatsonis, DN, 2001) |
| "We still do not have an ideal drug to treat acute severe hypertension in pregnancy." | 2.40 | Management of acute severe hypertension and encephalopathy. ( Mabie, WC, 1999) |
| "First, in premature labor, nifedipine is an appropriate alternative related with beta-mimetic or prostaglandin synthetase inhibitors agents, with good tocolytic properties and safe for both mother and baby." | 2.38 | [Nifedipine in gynecology and obstetrics]. ( Palma-Aguirre, JA; Rodríguez-Palomares, C, 1992) |
| "A review of the pathophysiology and treatment of pre-eclampsia indicates that vasospasm and vascular hyperreactivity are important elements in the disease process and its control." | 2.36 | Possible treatment of pre-eclampsia with calcium channel blocking agents. ( Zaret, GM, 1983) |
| "Nifedipine was the only aCCB used for this study population." | 1.38 | Antenatal calcium channel blocker exposure and subsequent patent ductus arteriosus in extremely low-birth-weight infants. ( Arzuaga, B; Lee, BH; McGuirl, J, 2012) |
| "Takayasu's arteritis is a chronic and non-specific disease of young women in reproductive age that primarily affects the aorta, its branches and the pulmonary artery." | 1.37 | [Takayasu's arteritis in pregnancy: report seven cases]. ( Carvajal-Valencia, JA; Chacón-Solís, AR; Estrada-Altamirano, A; Hernández-Pacheco, JA; Maya-Quiñones, JL; Valenzuela-Jirón, A, 2011) |
| "Pregnancy is associated with hemodynamic changes such as reduced vascular resistance and blood pressure." | 1.31 | Calcium channels contribute to the decrease in blood pressure of pregnant rats. ( Brochu, M; Cadorette, C; Poterek, M; Simaan, M; St-Louis, J, 2002) |
| "Primary pulmonary hypertension is a rare, incurable, and progressive disease." | 1.29 | Primary pulmonary hypertension in pregnancy: a case report. ( Asseryanis, E; Egarter, C; Kiss, H; Kneussl, M; Putz, D, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (9.47) | 18.7374 |
| 1990's | 40 (42.11) | 18.2507 |
| 2000's | 17 (17.89) | 29.6817 |
| 2010's | 23 (24.21) | 24.3611 |
| 2020's | 6 (6.32) | 2.80 |
| Authors | Studies |
|---|---|
| George, R | 1 |
| Thomas, C | 1 |
| Joy, CA | 1 |
| Varghese, B | 1 |
| Undela, K | 1 |
| Adela, R | 1 |
| van de Vusse, D | 1 |
| Mian, P | 1 |
| Schoenmakers, S | 1 |
| Flint, RB | 1 |
| Visser, W | 1 |
| Allegaert, K | 1 |
| Versmissen, J | 1 |
| Webster, LM | 2 |
| Reed, K | 1 |
| Myers, JE | 2 |
| Burns, A | 1 |
| Gupta, P | 1 |
| Patel, P | 1 |
| Wiesender, C | 1 |
| Seed, PT | 2 |
| Nelson-Piercy, C | 2 |
| Chappell, LC | 2 |
| Salama, M | 1 |
| Rezk, M | 2 |
| Gaber, W | 1 |
| Hamza, H | 1 |
| Marawan, H | 1 |
| Gamal, A | 1 |
| Abdallah, S | 1 |
| Soares, C | 1 |
| Gilson, M | 1 |
| Kantorowska, A | 1 |
| Heiselman, CJ | 1 |
| Halpern, TA | 1 |
| Akerman, MB | 1 |
| Elsayad, A | 1 |
| Muscat, JC | 1 |
| Sicuranza, GB | 1 |
| Vintzileos, AM | 1 |
| Heo, HJ | 1 |
| Bellos, I | 1 |
| Pergialiotis, V | 1 |
| Papapanagiotou, A | 1 |
| Loutradis, D | 1 |
| Daskalakis, G | 1 |
| Doherty, A | 1 |
| McLaughlin, K | 1 |
| Kingdom, JC | 1 |
| Mills, C | 1 |
| Watt-Coote, I | 1 |
| Khalil, A | 1 |
| Cruickshank, JK | 1 |
| Sridharan, K | 1 |
| Sequeira, RP | 1 |
| Reddy, S | 1 |
| Jim, B | 1 |
| Lemoine, ER | 1 |
| Karumanchi, SA | 1 |
| Alexander, JM | 1 |
| Wilson, KL | 1 |
| Ngamprasertwong, P | 1 |
| Habli, M | 1 |
| Boat, A | 1 |
| Lim, FY | 1 |
| Esslinger, H | 1 |
| Ding, L | 1 |
| Sadhasivam, S | 1 |
| Firoz, T | 1 |
| Magee, LA | 2 |
| MacDonell, K | 1 |
| Payne, BA | 1 |
| Gordon, R | 1 |
| Vidler, M | 1 |
| von Dadelszen, P | 1 |
| Vadhera, RB | 1 |
| Simon, M | 1 |
| Shi, Q | 1 |
| Leng, W | 1 |
| Yao, Q | 1 |
| Mi, C | 1 |
| Xing, A | 1 |
| Shekhar, S | 1 |
| Gupta, N | 2 |
| Kirubakaran, R | 1 |
| Pareek, P | 1 |
| Clark, SM | 1 |
| Dunn, HE | 1 |
| Hankins, GD | 1 |
| Sayyed, T | 1 |
| Masood, A | 1 |
| Dawood, R | 1 |
| Small, HY | 1 |
| Morgan, H | 1 |
| Beattie, E | 1 |
| Griffin, S | 1 |
| Indahl, M | 1 |
| Delles, C | 1 |
| Graham, D | 1 |
| Ozsvár, Z | 1 |
| Solymossi, Z | 1 |
| Monostory, K | 1 |
| Holzgreve, H | 1 |
| McGuirl, J | 1 |
| Arzuaga, B | 1 |
| Lee, BH | 1 |
| Hernández-Pacheco, JA | 1 |
| Estrada-Altamirano, A | 1 |
| Valenzuela-Jirón, A | 1 |
| Maya-Quiñones, JL | 1 |
| Carvajal-Valencia, JA | 1 |
| Chacón-Solís, AR | 1 |
| Cheung, CS | 1 |
| Li, TK | 1 |
| Lee, CP | 1 |
| Brown, MA | 1 |
| Buddle, ML | 1 |
| Farrell, T | 1 |
| Davis, GK | 1 |
| Valensise, H | 2 |
| Larciprete, G | 1 |
| Vasapollo, B | 1 |
| Novelli, G | 1 |
| Altomare, F | 1 |
| Andreoli, A | 1 |
| De Lorenzo, A | 1 |
| Arduini, D | 1 |
| Hodges, R | 1 |
| Barkehall-Thomas, A | 1 |
| Tippett, C | 1 |
| van Veen, AJ | 1 |
| Pelinck, MJ | 1 |
| van Pampus, MG | 1 |
| Erwich, JJ | 1 |
| Papatsonis, DN | 2 |
| Carbonne, B | 1 |
| Dekker, GA | 2 |
| Flenady, V | 1 |
| King, JF | 1 |
| Parasuraman, R | 1 |
| Gandhi, MM | 1 |
| Liversedge, NH | 1 |
| Ugwumadu, A | 1 |
| Dalmia, S | 1 |
| Deka, D | 1 |
| Mittal, S | 1 |
| Striuk, RI | 1 |
| Brytkova, IaV | 1 |
| Bukhonkina, IuM | 1 |
| Pavlova, LN | 1 |
| Coustan, DR | 1 |
| Zaret, GM | 1 |
| Ulmsten, U | 1 |
| Walters, BN | 1 |
| Redman, CW | 3 |
| Levin, AC | 1 |
| Doering, PL | 1 |
| Hatton, RC | 1 |
| Kiss, H | 1 |
| Egarter, C | 1 |
| Asseryanis, E | 1 |
| Putz, D | 1 |
| Kneussl, M | 1 |
| Jayawardana, J | 1 |
| Lekamge, N | 1 |
| Caruso, A | 1 |
| Ferrazzani, S | 1 |
| De Carolis, S | 1 |
| Romano, D | 1 |
| Mancinelli, S | 1 |
| De Carolis, MP | 1 |
| Manninen, A | 4 |
| Vuorinen, P | 1 |
| Laippala, P | 2 |
| Tuimala, R | 3 |
| Vapaatalo, H | 4 |
| Tranquilli, AL | 1 |
| Conti, C | 1 |
| Rezai, B | 1 |
| Garzetti, GG | 1 |
| Romanini, C | 2 |
| Childress, CH | 1 |
| Katz, VL | 1 |
| Ben-Ami, M | 1 |
| Giladi, Y | 1 |
| Shalev, E | 1 |
| Impey, L | 1 |
| Shalev, Y | 1 |
| Ben-Hur, H | 1 |
| Hagay, Z | 1 |
| Blickstein, I | 1 |
| Epstein, M | 1 |
| Ayzenberg, O | 1 |
| Gelven, A | 1 |
| Caspi, A | 1 |
| Ottman, EH | 1 |
| Gall, SA | 1 |
| Nootens, M | 1 |
| Rich, S | 1 |
| Kumar, N | 1 |
| Batra, YK | 1 |
| Bala, I | 1 |
| Gopalan, S | 1 |
| Jegasothy, R | 1 |
| Paranthaman, S | 1 |
| Wuorela, H | 1 |
| Serra-Serra, V | 1 |
| Kyle, PM | 1 |
| Chandran, R | 1 |
| Benedetto, C | 1 |
| Zonca, M | 1 |
| Giarola, M | 1 |
| Maulà, V | 1 |
| Chiarolini, L | 1 |
| Carandente, F | 1 |
| Gallery, ED | 1 |
| Györy, AZ | 1 |
| Hassall, JJ | 1 |
| Langton, PE | 1 |
| Millar, JA | 1 |
| Gazzolo, D | 1 |
| Visser, GH | 1 |
| Russo, A | 1 |
| Scopesi, F | 1 |
| Santi, F | 1 |
| Bruschettini, PL | 1 |
| Hall, DR | 2 |
| Odendaal, HJ | 2 |
| Oei, SG | 1 |
| Oei, SK | 1 |
| Brölmann, HA | 1 |
| Easterling, TR | 1 |
| Ralph, DD | 1 |
| Schmucker, BC | 1 |
| Mabie, WC | 2 |
| Neri, I | 1 |
| Facchinetti, F | 1 |
| Menghini, S | 1 |
| Volpe, A | 1 |
| Vermillion, ST | 1 |
| Scardo, JA | 1 |
| Newman, RB | 1 |
| Chauhan, SP | 1 |
| Smith, P | 1 |
| Anthony, J | 1 |
| Johanson, R | 1 |
| Steyn, DW | 1 |
| Smith, M | 1 |
| Bortolus, R | 1 |
| Ricci, E | 1 |
| Chatenoud, L | 1 |
| Parazzini, F | 1 |
| Hussein, M | 1 |
| Mooij, JM | 1 |
| Roujouleh, H | 1 |
| Lok, CA | 1 |
| Bos, JM | 1 |
| Geijn, HP | 1 |
| Yang, X | 1 |
| Liu, Y | 1 |
| Simaan, M | 1 |
| Cadorette, C | 1 |
| Poterek, M | 1 |
| St-Louis, J | 1 |
| Brochu, M | 1 |
| Duggan, PM | 1 |
| McCowan, LM | 1 |
| Stewart, AW | 1 |
| Palma-Aguirre, JA | 1 |
| Rodríguez-Palomares, C | 1 |
| Hirose, S | 1 |
| Yamada, A | 1 |
| Kasugai, M | 1 |
| Ishizuka, T | 1 |
| Tomoda, Y | 1 |
| Prevost, RR | 1 |
| Akl, SA | 1 |
| Whybrew, WD | 1 |
| Sibai, BM | 2 |
| Fairlie, FM | 1 |
| Metsä-Ketelä, T | 1 |
| Puzey, MS | 1 |
| Ackovic, KL | 1 |
| Lindow, SW | 2 |
| Gonin, R | 1 |
| Manninen, AK | 1 |
| Pirhonen, JP | 1 |
| Erkkola, RU | 1 |
| Ekblad, UU | 1 |
| Lurie, S | 1 |
| Fenakel, K | 1 |
| Friedman, A | 1 |
| Seabe, SJ | 1 |
| Moodley, J | 1 |
| Becker, P | 1 |
| Naden, RP | 1 |
| Rubin, PC | 1 |
| Horn, L | 1 |
| Ahokas, RA | 1 |
| Anderson, GD | 1 |
| Davies, N | 1 |
| Davey, DA | 1 |
| Smith, JA | 1 |
| Constantine, G | 1 |
| Beevers, DG | 1 |
| Reynolds, AL | 1 |
| Luesley, DM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Control Trial of Furosemide or Placebo With Usual Antihypertensives in the Antepartum Management of Severe Hypertension With Wide Pulse Pressure[NCT04615624] | Phase 3 | 65 participants (Actual) | Interventional | 2021-01-04 | Completed | ||
| A Comparison of Fetal Hemodynamic Measurements Between Pregnant Women Taking Anti-hypertensive Medication and Controls[NCT00759278] | 0 participants (Actual) | Observational | 2008-08-31 | Withdrawn (stopped due to No participants) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
20 reviews available for nifedipine and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Comparative efficacy and safety of oral nifedipine with other antihypertensive medications in the management of hypertensive disorders of pregnancy: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Nifedipine; Pregnancy; Pre | 2022 |
Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review.
Topics: Antihypertensive Agents; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; M | 2022 |
Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
Topics: Abruptio Placentae; Amlodipine; Antihypertensive Agents; Atenolol; Cesarean Section; Chronic Disease | 2020 |
Hemodynamic Complications in Pregnancy: Preeclampsia and Beyond.
Topics: Anticonvulsants; Antihypertensive Agents; Aspirin; Delivery, Obstetric; Female; Fetal Growth Retarda | 2020 |
Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
Topics: Antihypertensive Agents; Dose-Response Relationship, Drug; Female; Headache; Humans; Hydralazine; Hy | 2018 |
Hypertension and Pregnancy: Management and Future Risks.
Topics: Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Chronic Disease; Diuretics; Female; Human | 2019 |
Hypertensive emergencies of pregnancy.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Creatine; Diuretics; Emergency Medicine; Female; | 2013 |
Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
Topics: Administration, Oral; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension, Pregnancy- | 2014 |
Hypertensive emergencies in pregnancy.
Topics: Antihypertensive Agents; Eclampsia; Emergencies; Female; Humans; Hydralazine; Hypertension; Hyperten | 2014 |
Oral nifedipine versus intravenous labetalol for the treatment of severe hypertension in pregnancy.
Topics: Administration, Oral; Antihypertensive Agents; Female; Humans; Hypertension; Infusions, Intravenous; | 2015 |
Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis.
Topics: Administration, Intravenous; Administration, Oral; Adult; Antihypertensive Agents; Cost-Benefit Anal | 2016 |
A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension, | 2015 |
Possible treatment of pre-eclampsia with calcium channel blocking agents.
Topics: Calcium Channel Blockers; Eclampsia; Female; Fetus; Humans; Hypertension; Nifedipine; Placenta; Pre- | 1983 |
Use of nifedipine in the hypertensive diseases of pregnancy.
Topics: Female; Humans; Hydralazine; Hypertension; Nifedipine; Pre-Eclampsia; Pregnancy; Pregnancy Complicat | 1994 |
Nifedipine and its indications in obstetrics and gynecology.
Topics: Animals; Female; Fetus; Humans; Hypertension; Nifedipine; Pregnancy; Pregnancy Complications, Cardio | 1994 |
Management of acute severe hypertension and encephalopathy.
Topics: Acute Disease; Antihypertensive Agents; Brain Diseases; Female; Humans; Hypertension; Nifedipine; Ni | 1999 |
Calcium channel blockers in the management of preterm labor and hypertension in pregnancy.
Topics: Breast Feeding; Calcium Channel Blockers; Female; Humans; Hypertension; Maternal-Fetal Exchange; Nif | 2001 |
[Nifedipine in gynecology and obstetrics].
Topics: Amenorrhea; Antihypertensive Agents; Female; Fetus; Humans; Hypertension; Nifedipine; Obstetric Labo | 1992 |
Doppler flow velocimetry in hypertension in pregnancy.
Topics: Female; Fetus; Hemodynamics; Humans; Hypertension; Labetalol; Mass Screening; Nifedipine; Placenta; | 1991 |
Antihypertensive drugs in pregnancy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diazoxide; Diuretics; Female; Fetus; Humans; H | 1985 |
21 trials available for nifedipine and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Quantifying adherence to antihypertensive medication for chronic hypertension during pregnancy.
Topics: Adult; Antihypertensive Agents; Blood Pressure Determination; Chromatography, High Pressure Liquid; | 2019 |
Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: A multicenter randomized clinical trial.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Egypt; Female; Humans; Hypertension; Hypertens | 2019 |
Longitudinal changes in vascular function parameters in pregnant women with chronic hypertension and association with adverse outcome: a cohort study.
Topics: Adult; Antihypertensive Agents; Birth Weight; Black People; Blood Pressure; Chronic Disease; Cohort | 2019 |
RETRACTED: Nicorandil vs nifedipine for the treatment of preterm labour: a randomized clinical trial.
Topics: Adolescent; Adult; Double-Blind Method; Female; Fetal Diseases; Headache; Humans; Nicorandil; Nifedi | 2015 |
Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy.
Topics: Acute Disease; Blood Pressure; Capsules; Female; Humans; Hypertension; Nifedipine; Pregnancy; Pregna | 2002 |
A comparison of nifedipine with methyldopa in pregnancy induced hypertension.
Topics: Adult; Female; Humans; Hypertension; Methyldopa; Nifedipine; Pregnancy; Pregnancy Complications, Car | 1994 |
Nifedipine attenuates the hypertensive response to tracheal intubation in pregnancy-induced hypertension.
Topics: Administration, Sublingual; Adult; Anesthesia, Intravenous; Apgar Score; Blood Gas Analysis; Blood P | 1993 |
Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice.
Topics: Administration, Sublingual; Antihypertensive Agents; Calcium Channel Blockers; Female; Humans; Hydra | 1996 |
Intraplatelet free calcium and calcium-regulating hormones in plasma are not related to the antihypertensive effect of nifedipine in hypertensive pregnancy.
Topics: Adult; Blood Platelets; Calcium; Calcium Channel Blockers; Contraceptive Agents; Female; Humans; Hyd | 1995 |
Nifedipine reduces thromboxane A2 production by platelets without changing aggregation in hypertensive pregnancy.
Topics: Adult; Antihypertensive Agents; Blood Platelets; Blood Pressure; Female; Humans; Hypertension; In Vi | 1996 |
The addition of a diuretic to anti-hypertensive therapy for early severe hypertension in pregnancy.
Topics: Adult; Amiloride; Antihypertensive Agents; Diuretics; Drug Combinations; Drug Therapy, Combination; | 1998 |
Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Gruppo di Studio Ipertensione in Gravidanza.
Topics: Adult; Birth Weight; Calcium Channel Blockers; Delayed-Action Preparations; Female; Gestational Age; | 1998 |
24-hour ambulatory blood pressure monitoring: a comparison between transdermal glyceryl-trinitrate and oral nifedipine.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Analysis of Variance; Female; Humans; Hypert | 1999 |
A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Blood Pressure; Calcium Channel Blockers; | 1999 |
Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial.
Topics: Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hypertension; Ni | 2000 |
Nifedipine administered in pregnancy: effect on the development of children at 18 months.
Topics: Calcium Channel Blockers; Child Development; Female; Follow-Up Studies; Humans; Hypertension; Infant | 2000 |
[The effect of Nifedipine on postpartum blood loss in patients with pregnancy induced hypertension].
Topics: Calcium Channel Blockers; Female; Humans; Hypertension; Nifedipine; Postpartum Hemorrhage; Pregnancy | 2000 |
Antihypertensive drug effects on placental flow velocity waveforms in pregnant women with severe hypertension.
Topics: Arteries; Blood Flow Velocity; Double-Blind Method; Female; Humans; Hydralazine; Hypertension; Nifed | 1992 |
The effect of nifedipine on fetal umbilical artery Doppler waveforms in pregnancies complicated by hypertension.
Topics: Blood Flow Velocity; Blood Pressure; Double-Blind Method; Female; Heart Rate, Fetal; Humans; Hyperte | 1991 |
Nifedipine in acute hypertensive emergencies in pregnancy.
Topics: Acute Disease; Adolescent; Adult; Blood Pressure; Dihydralazine; Emergencies; Female; Humans; Hypert | 1989 |
The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy.
Topics: Adult; Blood Flow Velocity; Blood Pressure; Female; Humans; Hypertension; Nifedipine; Placenta; Preg | 1988 |
54 other studies available for nifedipine and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Nifedipine-Induced Shock in Pregnancy With Aortic Stenosis.
Topics: Aortic Valve Stenosis; Calcium Gluconate; Chest Pain; Electrocardiography; Female; Fetofetal Transfu | 2020 |
Identification of factors associated with delayed treatment of obstetric hypertensive emergencies.
Topics: Administration, Intravenous; Administration, Oral; Adult; After-Hours Care; Antihypertensive Agents; | 2020 |
Committee Opinion No. 692 Summary: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Drug Administration Routes; E | 2017 |
Committee Opinion No. 692: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Drug Administration Routes; E | 2017 |
Oral regimen management of acute hypertension in pregnancy.
Topics: Antihypertensive Agents; Female; Humans; Hypertension; Labetalol; Methyldopa; Nifedipine; Pregnancy; | 2019 |
Maternal hypotension during fetoscopic surgery: incidence and its impact on fetal survival outcomes.
Topics: Adult; Cohort Studies; Female; Fetal Death; Fetofetal Transfusion; Fetoscopy; Humans; Hypotension; I | 2013 |
Oral nifedipine or intravenous labetalol for severe hypertension?
Topics: Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Pra | 2016 |
Abnormal uterine artery remodelling in the stroke prone spontaneously hypertensive rat.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Female; Gestational Age; Hypertension; Nifedipine; | 2016 |
[Methyldopa-induced acute reactive hepatitis in pregnancy, drug-metabolizing capacity of the liver].
Topics: Adrenergic alpha-Agonists; Adult; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Blood Pres | 2010 |
[Hypertensive urgency or hypertensive emergency?].
Topics: Adult; Antihypertensive Agents; Blood Pressure Determination; Emergencies; Female; Follow-Up Studies | 2010 |
Antenatal calcium channel blocker exposure and subsequent patent ductus arteriosus in extremely low-birth-weight infants.
Topics: Calcium Channel Blockers; Case-Control Studies; Ductus Arteriosus, Patent; Female; Humans; Infant, N | 2012 |
[Takayasu's arteritis in pregnancy: report seven cases].
Topics: Adult; Antihypertensive Agents; Cesarean Section; Female; Fetal Growth Retardation; Follow-Up Studie | 2011 |
Maternal atrial fibrillation after sequential use of nifedipine and atosiban for treatment of preterm labor: case report.
Topics: Adult; Atrial Fibrillation; Drug Therapy, Combination; Female; Humans; Nifedipine; Obstetric Labor, | 2013 |
Nifedipine-induced changes in body composition in hypertensive patients at term.
Topics: Adult; Blood Pressure; Body Composition; Body Water; Calcium Channel Blockers; Electric Impedance; F | 2003 |
Maternal hypoxia associated with nifedipine for threatened preterm labour.
Topics: Adult; Dyspnea; Female; Heart Septal Defects, Ventricular; Humans; Hypoxia; Nifedipine; Obstetric La | 2004 |
Severe hypotension and fetal death due to tocolysis with nifedipine.
Topics: Adult; Female; Fetal Death; Humans; Hypotension; Nifedipine; Obstetric Labor, Premature; Pregnancy; | 2005 |
Severe hypotension and fetal death due to tocolysis with nifedipine.
Topics: Female; Fetal Death; Humans; Hypotension; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovasc | 2005 |
Nifedipine tocolysis associated atrial fibrillation responds to DC cardioversion.
Topics: Adult; Atrial Fibrillation; Electric Countershock; Female; Humans; Nifedipine; Obstetric Labor, Prem | 2006 |
Nifedipine-tocolysis-associated atrial fibrillation responds to DC cardioversion.
Topics: Atrial Fibrillation; Calcium Channel Blockers; Electric Countershock; Female; Humans; Nifedipine; Pr | 2007 |
Successful maternal and fetal outcome in a pregnancy with type V Takayasu's aortoarteritis.
Topics: Adult; Antihypertensive Agents; Arterial Occlusive Diseases; Calcium Channel Blockers; Diuretics; Fe | 2008 |
[Clinical efficacy of antihypertensive therapy of pregnant women with arterial hypertension with long acting nifedipine and bisoprolol].
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Blood Pressure; Calcium Channel Blockers; Delayed-Ac | 2008 |
A 40-year-old woman with diabetes contemplating pregnancy after gastric bypass surgery.
Topics: Adult; Antihypertensive Agents; Breast Feeding; Diabetes Mellitus, Type 2; Female; Gastric Bypass; G | 2008 |
Treatment of normotensive and hypertensive patients with preterm labor using oral nifedipine, a calcium antagonist.
Topics: Adult; Female; Humans; Hypertension; Infant, Newborn; Nifedipine; Obstetric Labor, Premature; Pregna | 1984 |
Treatment of severe pregnancy-associated hypertension with the calcium antagonist nifedipine.
Topics: Adolescent; Adult; Blood Pressure; Female; Humans; Hypertension; Nifedipine; Pilot Projects; Pregnan | 1984 |
Primary pulmonary hypertension in pregnancy: a case report.
Topics: Adult; Female; Heparin, Low-Molecular-Weight; Humans; Hypertension, Pulmonary; Nifedipine; Pregnancy | 1995 |
The use of nifedipine as first-line hypotensive therapy in gestational hypertension.
Topics: Adult; Female; Gestational Age; Humans; Hypertension; Infant, Newborn; Nifedipine; Pre-Eclampsia; Pr | 1994 |
Atrial natriuretic peptide and cyclic guanosine-3'5'-monophosphate in hypertensive pregnancy and during nifedipine treatment.
Topics: Administration, Oral; Adult; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Female; Humans; | 1994 |
Nifedipine reduces pressor responsiveness to angiotensin II in pregnant women.
Topics: Adult; Angiotensin II; Blood Pressure; Female; Humans; Hypertension; Nifedipine; Pregnancy; Pregnanc | 1994 |
The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade.
Topics: Adult; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hypertension; Magnesium Sulfate | 1994 |
Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks.
Topics: Adult; Female; Fetal Distress; Humans; Hypertension; Hypotension; Nifedipine; Pregnancy; Pregnancy C | 1993 |
Successful delivery following myocardial ischemia during the second trimester of pregnancy.
Topics: Acute Disease; Adult; Atenolol; Cardiac Catheterization; Coronary Angiography; Female; Heparin; Huma | 1993 |
Myocardial infarction in the third trimester of pregnancy secondary to an aortic valve thrombus.
Topics: Adult; Aortic Valve; Female; Heart Valve Prosthesis; Heparin; Humans; Myocardial Infarction; Nifedip | 1993 |
Successful management of labor and delivery in primary pulmonary hypertension.
Topics: Adenosine; Adult; Delivery, Obstetric; Female; Humans; Hypertension, Pulmonary; Nifedipine; Pregnanc | 1993 |
The effect of nifedipine and methyldopa on maternal cerebral circulation.
Topics: Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Cerebral Arteries; Cerebrovascular Cir | 1997 |
24-hour blood pressure monitoring to evaluate the effects of nifedipine in pre-eclampsia and in chronic hypertension in pregnancy.
Topics: Adult; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Chronic Dise | 1997 |
Sublingual nifedipine in human pregnancy.
Topics: Administration, Sublingual; Apgar Score; Birth Weight; Calcium Channel Blockers; Female; Humans; Hyp | 1997 |
Withdrawal of nifedipine capsules: jeopardising the treatment of acute severe hypertension in pregnancy?
Topics: Acute Disease; Australia; Calcium Channel Blockers; Contraindications; Drug Labeling; Female; Humans | 1998 |
Withdrawal of nifedipine capsules: jeopardising the treatment of acute severe hypertension in pregnancy?
Topics: Acute Disease; Administration, Oral; Administration, Sublingual; Blood Pressure; Calcium Channel Blo | 1998 |
Withdrawal of nifedipine capsules: jeopardising the treatment of acute severe hypertension in pregnancy?
Topics: Acute Disease; Administration, Oral; Australia; Blood Pressure; Calcium Channel Blockers; Capsules; | 1998 |
Pregnancy-induced hypertension, antihypertensive drugs and the development of fetal behavioural states.
Topics: Antihypertensive Agents; Cohort Studies; Embryo, Mammalian; Embryonic and Fetal Development; Female; | 1998 |
Myocardial infarction during nifedipine therapy for preterm labor.
Topics: Adult; Calcium Channel Blockers; Female; Humans; Myocardial Infarction; Nifedipine; Obstetric Labor, | 1999 |
Pulmonary hypertension in pregnancy: treatment with pulmonary vasodilators.
Topics: Adult; Antihypertensive Agents; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Nifedipine; P | 1999 |
Nifedipine in pregnancy.
Topics: Drug Interactions; Female; Humans; Hypertension; Nifedipine; Pregnancy; Pregnancy Complications, Car | 2000 |
Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
Topics: Antihypertensive Agents; Apgar Score; Cesarean Section; Comorbidity; Disease Susceptibility; Female; | 2001 |
Calcium channels contribute to the decrease in blood pressure of pregnant rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2002 |
The effect of nifedipine and dipyridamole on the Doppler blood flow waveforms of umbilical and uterine arteries in hypertensive pregnant women.
Topics: Adult; Arteries; Blood Flow Velocity; Dipyridamole; Female; Humans; Hypertension; Nifedipine; Pregna | 1992 |
Oral nifedipine pharmacokinetics in pregnancy-induced hypertension.
Topics: Administration, Oral; Adult; Female; Half-Life; Humans; Hypertension; Metabolic Clearance Rate; Nife | 1992 |
Nifedipine increases urinary excretion of prostacyclin metabolite in hypertensive pregnancy.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Blood Pressure; Catecholamines; Creatinine; Dinoprostone; Epopr | 1991 |
Blood pressure, plasma renin activity and calcium metabolism in hypertensive pregnancy: the effect of nifedipine.
Topics: Adult; Blood Pressure; Calcium; Electrolytes; Female; Humans; Hypertension; Nifedipine; Pregnancy; P | 1990 |
Uterine and fetal flow velocity waveforms in hypertensive pregnancy: the effect of a single dose of nifedipine.
Topics: Adult; Apgar Score; Birth Weight; Blood Flow Velocity; Cerebral Arteries; Cesarean Section; Female; | 1990 |
Effect of nifedipine on fetal heart rate in the treatment of severe pregnancy-induced hypertension.
Topics: Female; Heart Rate, Fetal; Humans; Hypertension; Nifedipine; Pregnancy; Pregnancy Complications, Car | 1990 |
Preeclampsia: platelets and antiplatelet therapy.
Topics: Aspirin; Blood Coagulation; Blood Platelets; Diagnosis, Differential; Female; Fetus; Humans; Hyperte | 1988 |
Nifedipine does not adversely affect uteroplacental blood flow in the hypertensive term-pregnant rat.
Topics: Animals; Female; Hemodynamics; Hypertension; Nifedipine; Placenta; Pregnancy; Pregnancy Complication | 1988 |
Nifedipine as a second line antihypertensive drug in pregnancy.
Topics: Adult; Atenolol; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Hypertensio | 1987 |